- welcomes this package of measures;
- recognises that need to pay particular attention to the situation of smaller EU Member States, Cyprus, Ireland and Malta in particula;
- stresses in particular the central role of a functioning, fair and efficient internal market;
- welcomes the packaging requirements for UK products included in the package;
- draws attention to the need for a timely and sustainable solution, which should be developed within the framework of the European Pharmaceutical Strategy.